Adenosine A(2A) receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 1, 1996, Pages 48-56

  Jin, Shaoyu ^a   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Acetylcholine; Adenosine receptors; Catecholamine; Hippocampus; Presynaptic receptors; Striatum

Indexed keywords

2 CHLOROADENOSINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A2 RECEPTOR; CATECHOLAMINE; PRESYNAPTIC RECEPTOR; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYLTHEOPHYLLINE; 8-CYCLOPENTYL-1,3-DIMETHYLXANTHINE; ACETYLCHOLINE; ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; KF 17387; PHENETHYLAMINE DERIVATIVE; THEOPHYLLINE; XANTHINE DERIVATIVE;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; MALE; NONHUMAN; RAT; ANIMAL; DRUG EFFECT; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

2-CHLOROADENOSINE; ACETYLCHOLINE; ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; CATECHOLAMINES; CORPUS STRIATUM; HIPPOCAMPUS; MALE; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; THEOPHYLLINE; XANTHINES;

EID: 0030614735     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004917     Document Type: Article

References (53)

1. 3 receptors in rat brain. Mol Pharmacol 48:1038-1045
2. Alexander SP, Reddington M (1989) The cellular localization of adenosine receptors in rat striatum. Neuroscience 28:645-651
3. Amaral DJ, Kurz J (1985) An analysis of the origin of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat. J Comp Neurol 240:37-59
4. Arunlakshana O, Schild HO (1995) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48-58
5. 2a receptors associated with norepinephrine release and their desensitization in the rat nucleus tractus solitarius. J Neurochem 65:1604-1611
6. 2b adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol 47:801-814
7. 14C]acetylcholine release from rat cortex. J Pharmacol Exp Ther 277:193-197
8. 2a purine receptors regulate striatal acetylcholine release. J Neurochem 55:31-38
9. 3H]-NECA in rat striatal membranes. Mol Pharmacol 29:331-346
10. 1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedeberg's Arch Pharmacol 335:59-63
11. 1 receptors. J Pharmacol Exp Ther 273:637-642
12. Catania MV, Sortino MA, Rampello L, Canonico PL, Nicoletti F (1991) Adenosine deaminase increases release of excitatory amino acids through a mechanism independent of adenosine depletion. Neuropharmacology 30:153-159
13. 2a receptors in the rat hipocampus. Brain Res 649:208-216
14. 3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem 63: 207-214
15. 2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus. Neurosci Lett 196: 41-44
16. 2A receptors. Naunyn-Schmiedeberg's Arch Pharmacol 353:261-271
17. Dunwiddie TV, Hoffer BJ, Fredholm BB (1981) Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn-Schmiedeberg's Arch Pharmacol 316:326-330
18. Dunwiddie TV, Fredholm BB, Jonzon B, Sandberg G (1985) The adenosine receptor activity of EMD 28422, a purine derivative with reported actions on benzodiazepine receptors. Br J Pharmacol 84:625-630
19. 1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience 22:813-826
20. 2 dopamine receptors in rat striatum. Mol Brain Res 14:186-195
21. 1-receptor-mediated inhibition of evoked acetylcholine release in the rat hippocampus does not depend on protein kinase C. Acta Physiol Scand 140:245-255
22. 3H]-acetylcholine release from rat hippocampus. J Neurochem 54:1386-1390
23. Fredholm BB (1995) Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 76:93-101
24. Fredholm BB, Dunwiddie TV (1988) How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130-134
25. Fredholm BB, Abracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156
26. Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133-139
27. Goncalves J, Queiroz G (1993) Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 348:367-371
28. 2 adenosine receptor antagonist in vivo. J Pharmacol Exp Ther 267:1304-1310
29. Jacobson KA, van Galen PJM, Williams M (1992) Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 35:407-422
30. 3H]CGS 21680. Eur J Pharmacol 168:243-246
31. 2 receptor stimulation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J Pharamcol Exp Ther 267:801-808
32. 3H]CGS 21680 to rat brain using autoradiography. Neuropharmacology 34:393-403
33. 2 adenosine receptor binding and on mRNA levels. Naunyn-Schmiedeberg's Arch Pharmacol 347:407-414
34. 3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur J Pharmacol, Mol Pharmacol Sect 247:103-110
35. Johansson B, Lindström K, Fredholm BB (1994) Differences in the regional and cellular localization of c-fos mRNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59:837-849
36. Kenakin T (1993) Pharmacologic analysis of drug-receptor interaction, 2nd edn. Raven Press, New York
37. 3H]acetylcholine release. J Neurochem 62:960-966
38. Kirkpatrick KA, Richardson PJ (1993) Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes. Br J Pharmacol 110:949-954
39. 2A receptor-mediated modulation of striatal GABA and ACh release. Br J Pharmacol 113:43-48
40. 1 receptor in rat cerebral cortex. Neurosci Lett 209:181-184
41. Linden J (1989) Adenosine deaminase for removing adenosine: how much is enough? Trends Pharmacol Sci 10:260-262
42. 2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther 252:1134-1141
43. Martin M, Huguet J, Centelles JJ, Franco R (1995) Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol 155:4630-4643
44. 2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience 42:697-706
45. 3H]-CGS 21680 as a ligand. Naunyn-Schmiedeberg's Arch Pharmacol 342:85-89
46. Rainnie DG, Grunze HCR, McCarley RW, Greene RW (1994) Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science 263:689-692
47. Richardson IW, Szerb JC (1974) The release of labelled acetylcholine and choline from electrically stimulated brain slices. Br J Pharmacol 52:499-507
48. Richardson PJ, Brown SJ, Bailyes EM, Luzio JP (1987) Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses. Nature 327:232-234
49. 1 adenosine receptors in pig brain cortical membranes. J Neurochem 66:1675-1682
50. 1 dopamine receptor. Brain Res 519:333-337
51. 2 antagonists. J Med Chem 35:2342-2345
52. 2 receptors: structure-function relationships. Med Res Rev 12:423-471
53. Wainer BH, Levey AI, Rye DB, Mesulam MM, Mufson EJ (1985) Cholinergic and non-cholinergic septohippocampal pathways. Neurosci Lett 54:45-52